Mycotopia Therapies, Inc. (CIK: 0001763329) EDGAR, Information, Filings... CompaniesBIO.Com

Mycotopia Therapies, Inc.

Mailing address
480 22ND STREET, HEYBURN, Nevada, 83336
Phone
208-677-2020
State location
Idaho
State of incorporation
Nevada
Fiscal year end
December 31
SIC
5141 - (CF Office: Office of Trade & Services) WHOLESALE-GROCERIES, GENERAL LINE
Filings
N/A

Mycotopia Therapies, Inc. (CIK: 0001763329) is an American company incorporated in the state of Idaho. Head office is located at 480 22ND STREET, HEYBURN, Idaho, 83336. Work in the industry 5141 - (CF Office: Office of Trade & Services) WHOLESALE-GROCERIES, GENERAL LINE. Mycotopia Therapies, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

20/20 Global, Inc. from 2019-31-Jan to 2021-19-May

Owner	Filings	Transaction Date	Type of Owner
Williams Mark D.	0001769059	Jul-28-2020	director, 10 percent owner, officer: President, CEO & CFO
Gibson Colin	0001768925	Jun-17-2019	director, 10 percent owner, officer: Vice President

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Mycotopia Therapies, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001096906-24-001849 (33 Act) Size: KB	Sep-13-2024	333-282128 241298805
8-K	Document	Current report filing Acc-no: 0001096906-24-001786 (34 Act) Size: KB	Aug-21-2024	000-56022 241226763
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-24-001763 (34 Act) Size: KB	Aug-19-2024	000-56022 241219430
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001096906-24-001725 (34 Act) Size: KB	Aug-14-2024	000-56022 241209640
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-24-001146 (34 Act) Size: KB	May-15-2024	000-56022 24949589
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001096906-24-000907 (34 Act) Size: KB	Apr-23-2024	000-56022 24862248
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001096906-24-000699 (34 Act) Size: KB	Apr-01-2024	000-56022 24810042
8-K	Document	Current report filing Acc-no: 0001096906-24-000650 (34 Act) Size: KB	Mar-28-2024	000-56022 24797564
DEF 14C	Document	Definitive information statements Acc-no: 0001096906-24-000477 (34 Act) Size: KB	Mar-18-2024	000-56022 24757586
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001096906-24-000121 (34 Act) Size: KB	Jan-29-2024	000-56022 24574362
8-K	Document	Current report filing Acc-no: 0001096906-23-002316 (34 Act) Size: KB	Dec-05-2023	000-56022 231464582
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002130 (34 Act) Size: KB	Nov-13-2023	000-56022 231394925
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001096906-23-002096 (34 Act) Size: KB	Nov-06-2023	000-56022 231379125
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002094 (34 Act) Size: KB	Nov-06-2023	000-56022 231379077
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002008 (34 Act) Size: KB	Oct-17-2023	000-56022 231330298
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002006 (34 Act) Size: KB	Oct-17-2023	000-56022 231330231
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001096906-23-002003 (34 Act) Size: KB	Oct-17-2023	000-56022 231329998
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-001623 (34 Act) Size: KB	Aug-17-2023	000-56022 231181165
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001096906-23-001605 (34 Act) Size: KB	Aug-14-2023	000-56022 231172124
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-001409 (34 Act) Size: KB	Jul-14-2023	000-56022 231088618

Recent 20 filings. View all Mycotopia Therapies, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Mycotopia Therapies, Inc. overview
Mycotopia Therapies, Inc. job
Mycotopia Therapies, Inc. stock
Mycotopia Therapies, Inc. ownership
Mycotopia Therapies, Inc. CEO
Mycotopia Therapies, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.